Compositions and methods of treating Facioscapulohumeral muscular dystrophy
US11525137B2 · kind B2 · utility
9Cited by
190References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 12, 2021 |
| Grant date | Dec 13, 2022 |
| Priority date | — |
| Expiry date | Mar 12, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/35
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating Facioscapulohumeral muscular dystrophy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.